Health Catalyst teams up with MedRythms to help stroke patients walk, Vivify Health shines a light on telemedicine adoption, and more portfolio company news

This month’s Portfolio Spotlight includes stories on telehealth, featuring Infectious Disease Connect and Vivify Health, as well as a look into the innovative work being done as a result of Health Catalyst collaborating with MedRythms. Cavulus rounds out the news with a profile on how its new pricing structure is geared to help start-ups in the Medicare Advantage space.

Cavulus logo image

Cavulus recently introduced a new pricing structure designed for start-ups in the Medicare Advantage space. The structure is ideal for start-ups due to its predictable approach, including a fixed infrastructure cost, scalable components, and the fact that there are no seat licenses or per-user fees.


health catalyst logo

Health Catalyst’s new life science business is teaming up with MedRythms to develop a new digital therapeutic for stroke survivors. The digital therapeutic will combine sensor data, auditory stimulation, and artificial intelligence to create a new type of interactive music therapy to help patients regain their ability to walk.


Infectious Disease Connect logo image

New portfolio company Infectious Disease Connect was recently featured in mHealth Intelligence regarding telehealth’s role in treating infectious diseases. The story highlights the fact that solutions have been rolled out in 15 facilities and impressively, have resulted in all patients being successfully treated via the telemedicine solution.


A new study from Vivify Health highlights the need to improve access to virtual care. Results show that 83 percent of consumers are interested in receiving virtual care, but only 17 percent have access to it. Vivify hopes that will change in the coming years as regulatory and industry barriers to widespread adoption appear primed for change.

You Might Also Like…

more from the newsletter